High serum bilirubin concentrations preserve coronary flow reserve and coronary microvascular functions

被引:64
作者
Gullu, H
Erdogan, D
Tok, D
Topcu, S
Caliskan, M
Ulus, T
Muderrisoglu, H
机构
[1] Baskent Univ, Konya Teaching & Med Res Ctr, Dept Cardiol, Konya, Turkey
[2] Baskent Univ, Fac Med, Dept Cardiol, TR-06490 Ankara, Turkey
关键词
coronary flow reserve; bilirubin; echocardiography;
D O I
10.1161/01.ATV.0000185806.61430.7c
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Elevated serum bilirubin concentrations protect against atherosclerotic diseases; however, it is not clear whether higher serum bilirubin concentrations in physiological ranges work in favor of the cardiovascular system in younger persons with no cardiovascular risk factors. Accordingly, we investigated the effects of high, intermediate, and low serum bilirubin concentrations on coronary flow reserve (CFR). Methods and Results-Fifty-two healthy subjects with hyperbilirubinemia (total bilirubin 1.43 +/- 0.33 mg/dL; mean age 35.9 +/- 7.3), 55 subjects with intermediate bilirubin level (total bilirubin: 0.69 +/- 0.11 mg/dL; mean age: 36.4 +/- 6.8), and 53 healthy subjects with hypobilirubinemia (total bilirubin 0.37 +/- 0.08 mg/dL; mean age, 37.6 +/- 6.6) were studied. Transthoracic second harmonic Doppler echocardiography examination was performed using an Acuson Sequoia C256 Echocardiography System. Coronary diastolic peak flow velocities were measured at baseline and after dipyridamole infusion (0.84 mg/kg over 6 minutes). CFR was calculated as the ratio of hyperemic to baseline diastolic peak velocities. Demographic features, coronary risk factors, echocardiographic measurements, and biochemical measurements were similar among the 3 groups, except high-sensitivity C-reactive protein (hsCRP). CFR values were significantly higher in subjects with high bilirubin concentrations than those were in the intermediate and the low bilirubin groups (3.19 +/- 0.73; 2.75 +/- 0.42; 2.56 +/- 0.52, respectively; P<0.0001), and hsCRP levels were significantly lower in subjects with high bilirubin concentrations than those in both intermediate and low bilirubin groups (1.4 +/- 1.0, 2.0 +/- 1.7, 3.0 +/- 1.9 mg/L, respectively; P<0.001). hsCRP levels correlated with total bilirubin concentration and with CFR. Conclusion-Elevated serum bilirubin concentrations protect from CFR impairment, coronary microvascular dysfunction, and possibly coronary atherosclerosis.
引用
收藏
页码:2289 / 2294
页数:6
相关论文
共 39 条
[1]   VARIATION OF INITIAL SERUM BILIRUBIN RISE IN NEWBORN-INFANTS WITH TYPE OF ILLNESS [J].
BENARON, DA ;
BOWEN, FW .
LANCET, 1991, 338 (8759) :78-81
[2]  
BREIMER LH, 1994, CLIN CHEM, V40, P1987
[3]  
BREIMER LH, 1995, CLIN CHEM, V41, P1504
[4]   Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome [J].
Britten, MB ;
Zeiher, AM ;
Schächinger, V .
CORONARY ARTERY DISEASE, 2004, 15 (05) :259-264
[5]   Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine - A noninvasive, rapid and effective method for coronary flow reserve assessment [J].
Caiati, C ;
Zedda, N ;
Montaldo, C ;
Montisci, R ;
Iliceto, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) :122-130
[6]   New noninvasive method for coronary flow reserve assessment - Contrast-enhanced transthoracic second harmonic echo Doppler [J].
Caiati, C ;
Montaldo, C ;
Zedda, N ;
Bina, A ;
Iliceto, S .
CIRCULATION, 1999, 99 (06) :771-778
[7]   HYPERBILIRUBINEMIA RESULTS IN REDUCED OXIDATIVE INJURY IN NEONATAL GUNN-RATS EXPOSED TO HYPEROXIA [J].
DENNERY, PA ;
MCDONAGH, AF ;
SPITZ, DR ;
RODGERS, PA ;
STEVENSON, DK .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 19 (04) :395-404
[8]   ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].
DEVEREUX, RB ;
REICHEK, N .
CIRCULATION, 1977, 55 (04) :613-618
[9]   Total serum bilirubin and risk of cardiovascular disease in the Framingham Offspring Study [J].
Djoussé, L ;
Levy, D ;
Cupples, LA ;
Evans, JC ;
D'Agostino, RB ;
Ellison, RC .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (10) :1196-+
[10]   THE ROLE OF LIPID-PEROXIDATION AND ANTIOXIDANTS IN OXIDATIVE MODIFICATION OF LDL [J].
ESTERBAUER, H ;
GEBICKI, J ;
PUHL, H ;
JURGENS, G .
FREE RADICAL BIOLOGY AND MEDICINE, 1992, 13 (04) :341-390